The Cold, Cough, and Sore Throat Remedies Market size was estimated USD 7.12 billion in 2022 and is expected to reach USD 10.4 billion by 2030 at a CAGR of 4.4% during the forecast period of 2023-2030.
The market for cold, cough, and sore throat remedies is expected to expand quickly due to rising rates of cold and cough infections, affordable prices, widespread Drug availability, and patient demand for treatments that are both quick and long-lastingly effective. One of the key factors impacting market expansion is the rising demand for such therapeutic items. Other significant factors are the expansion of the child, elderly, and female populations, as well as the increased tendency to self-diagnose and self-treat minor illnesses. Due to the increased prevalence of cold and cough infections, low pricing, extensive Drug availability, and patient demand for treatments that are both rapid and long-lastingly effective, the market for cold, cough, and sore throat therapies is predicted to grow quickly. The increased demand for such medicinal goods is one of the major factors influencing market development. The growing numbers of children, the elderly, and women, as well as the rising propensity to self-diagnose and self-treat minor ailments, are other important reasons.
DRIVERS
Respiratory Infection Prevalence Changing Ways of Life, Enhanced Knowledge, and Drug Innovation:
The high incidence of respiratory diseases such as the common cold and flu, which prompts people to look for over-the-counter medications for symptom alleviation, is what drives the market for cold, cough, and sore throat remedies. Due to weakened immune systems caused by modern lifestyles, stress, and pollution exposure, people are more susceptible to respiratory infections, which increases the need for treatments. Higher Drug adoption is a result of increasing consumer awareness of the accessibility and efficacy of various treatments, as well as of advertising and marketing initiatives. The introduction of new and more efficient treatments as a result of ongoing research and development initiatives fuels market expansion.
RESTRAIN
Concerns about side effects and safety, generic competition, and seasonal demand.
OPPORTUNITY
Combination therapies, online retailing, natural and herbal remedies, and emerging markets.
Manufacturers have a chance to create and promote treatments with alleged health advantages as a result of the rising demand for natural and herbal goods. New distribution channels are made possible by the emergence of e-commerce and online shopping, allowing for greater customer access and potential market expansion. Untapped markets for cures for colds, coughs, and sore throats are presented by emerging nations' expanding economies and growing healthcare facilities. Combination medicines that address many ailments may draw customers searching for all-around relief.
CHALLENGES
Restrictive Rules and Pricing Pressure.
War may put a burden on a region's healthcare system, diverting resources and attention away from necessary healthcare requirements. The distribution and accessibility of healthcare items, such as treatments for colds, coughs, and sore throats, may be impacted by this resource reallocation. Regulatory Environment The import and export of pharmaceutical items may be impacted by changes in trade rules and regulations brought on by geopolitical conflicts. The dynamics of the market and the accessibility of solutions in various areas may vary as a result. Consumer Priorities may change during periods of uncertainty or crisis, and individuals may place a greater emphasis on fundamental requirements than on over-the-counter medications for common diseases. effect on world markets Geopolitical unrest and the Russian-Ukrainian conflict might have an impact on international trade, investor relations, and financial markets. Confidence among investors and trade relations These macroeconomic variables may have an indirect effect on the healthcare sector as a whole, including the market for medicines for colds, coughs, and sore throats.
IMPACT OF ONGOING RECESSION
Consumer Stockpiling During uncertain economic times, some customers could hoard drugs, such as cold, cough, and sore throat treatments, which might cause sales to briefly increase. Impact on Marketing and Advertising During a recession, businesses may cut back on their marketing and advertising expenditures, which might have an impact on both brand awareness and the promotion of cold, cough, and sore throat medicines. government initiatives and financial aid Governments may establish programmes or subsidies to increase access to healthcare as a result of economic downturns. This might have an impact on the demand for and accessibility of over-the-counter treatments, depending on the exact actions implemented. Impact on Retail Channels Recession-related changes in consumer behaviour may have an impact on how cold, cough, and sore throat medications are sold through retail channels.
By Drug
Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others
By Doses
Oral Syrups
Tablets/Pills
Nasal Drops
Lozenges
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Supermarkets/Hypermarkets
E-Commerce/Online Pharmacies
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
REGIONAL ANALYSES
In terms of revenue share, Asia Pacific dominated the market for cold, cough, and sore throat medicines globally. Over the course of the prediction, the area is anticipated to maintain its supremacy. This can be linked to rising consumer disposable income levels, increased consumer knowledge of these items, and rising consumer desire for natural treatments. Over the predicted period, it is also anticipated that rising respiratory illness rates brought on by altered weather patterns may increase Drug demand.
Due to increased consumer expenditure on healthcare goods that provide prompt relief from symptoms like congestion, runny nose and eyes, sneezing and coughing, etc., brought on by common colds or the flu, North America accounted for a sizeable portion of the market. Additionally, a rise in the sales tax on over-the-counter medicines imposed by several states, such as New York (4-8%) and added to federal taxes, makes it more expensive for consumers to purchase OTC medicines like cough syrups, which leads to lower consumption and adversely affects the regional economy.
The Major Key players are, Reckitt Benckiser, Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca ple., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co., and others.
India's Ministry of AYUSH: In February 2023, the budget for India's Ministry of AYUSH (Ayurveda, Yoga, Naturopathy, Unani, Siddha, and Homoeopathy) increased by 19.7% from the previous year and now totals an estimated US$ 444.7 million.
| Report Attributes | Details |
| Market Size in 2022 | US$ 7.12 Bn |
| Market Size by 2030 | US$ 10.4 Bn |
| CAGR | CAGR of 4.4 % From 2023 to 2030 |
| Base Year | 2022 |
| Forecast Period | 2023-2030 |
| Historical Data | 2020-2021 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Drug (Antihistamines, Expectorants, Bronchodilators, Decongestants, Antibiotics, Others) • By Doses (Oral Syrups, Tablets/Pills, Nasal Drops, Lozenges, Others) • By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets/Hypermarkets, E-Commerce/Online Pharmacies) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Reckitt Benckiser, Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca ple., Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co. |
| Key Drivers | • Respiratory Infection Prevalence Changing Ways of Life, Enhanced Knowledge, and Drug Innovation |
| Market Restraints | • Concerns about side effects and safety, generic competition, and seasonal demand. |
Ans: The Cold, Cough, and Sore Throat Remedies Market is expected to grow at a 4.4% CAGR from 2023 to 2030.
Ans: According to our analysis, the Cold, Cough, and Sore Throat Remedies Market is anticipated to reach USD 10.4 billion by 2030.
Ans: The prominent players in the Cold, Cough, and Sore Throat Remedies Market are Reckitt Benckiser, Group PLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca ple.
Ans: Recall and failure of cold, cough, and sore throat remedies is one of the major factors that is expected to hamper growth of the market over the forecast period.
Ans: Yes, you may request customization based on your company's needs.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Cold, Cough, and Sore Throat Remedies Market, By Drug
8.1 Antihistamines
8.2 Expectorants
8.3 Bronchodilators
8.4 Decongestants
8.5 Antibiotics
8.6 Others
9. Cold, Cough, and Sore Throat Remedies Market, By Doses
9.1 Oral Syrups
9.2 Tablets/Pills
9.3 Nasal Drops
9.4 Lozenges
9.5 Others
10. Cold, Cough, and Sore Throat Remedies Market, By Distribution Channel
10.1 Hospital Pharmacies
10.2 Retail Pharmacies
10.3 Drug Stores
10.4 Supermarkets/Hypermarkets
10.5 E-Commerce/Online Pharmacies
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Cold, Cough, and Sore Throat Remedies Market by country
11.2.2North America Cold, Cough, and Sore Throat Remedies Market by Drug
11.2.3 North America Cold, Cough, and Sore Throat Remedies Market by Doses
11.2.4 North America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.2.5 USA
11.2.5.1 USA Cold, Cough, and Sore Throat Remedies Market by Drug
11.2.5.2 USA Cold, Cough, and Sore Throat Remedies Market by Doses
11.2.5.3 USA Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.2.6 Canada
11.2.6.1 Canada Cold, Cough, and Sore Throat Remedies Market by Drug
11.2.6.2 Canada Cold, Cough, and Sore Throat Remedies Market by Doses
11.2.6.3 Canada Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.2.7 Mexico
11.2.7.1 Mexico Cold, Cough, and Sore Throat Remedies Market by Drug
11.2.7.2 Mexico Cold, Cough, and Sore Throat Remedies Market by Doses
11.2.7.3 Mexico Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Cold, Cough, and Sore Throat Remedies Market by country
11.3.1.2 Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.1.3 Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.1.4 Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.1.5 Poland
11.3.1.5.1 Poland Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.1.5.2 Poland Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.1.5.3 Poland Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.1.6 Romania
11.3.1.6.1 Romania Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.1.6.2 Romania Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.1.6.4 Romania Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.1.7 Turkey
11.3.1.7.1 Turkey Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.1.7.2 Turkey Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.1.7.3 Turkey Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.1.8.2 Rest of Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.1.8.3 Rest of Eastern Europe Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2 Western Europe
11.3.2.1 Western Europe Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.2 Western Europe Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.3 Western Europe Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.4 Germany
11.3.2.4.1 Germany Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.4.2 Germany Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.4.3 Germany Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.5 France
11.3.2.5.1 France Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.5.2 France Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.5.3 France Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.6 UK
11.3.2.6.1 UK Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.6.2 UK Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.6.3 UK Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.7 Italy
11.3.2.7.1 Italy Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.7.2 Italy Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.7.3 Italy Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.8 Spain
11.3.2.8.1 Spain Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.8.2 Spain Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.8.3 Spain Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.9 Netherlands
11.3.2.9.1 Netherlands Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.9.2 Netherlands Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.9.3 Netherlands Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.10 Switzerland
11.3.2.10.1 Switzerland Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.10.2 Switzerland Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.10.3 Switzerland Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.11.1 Austria
11.3.2.11.2 Austria Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.11.3 Austria Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.11.4 Austria Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.3.2.12 Rest of Western Europe
11.3.2.12.1 Rest of Western Europe Cold, Cough, and Sore Throat Remedies Market by Drug
11.3.2.12.2 Rest of Western Europe Cold, Cough, and Sore Throat Remedies Market by Doses
11.3.2.12.3 Rest of Western Europe Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4 Asia-Pacific
11.4.1 Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by country
11.4.2 Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.3 Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.4 Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.5 China
11.4.5.1 China Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.5.2 China Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.5.3 China Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.6 India
11.4.6.1 India Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.6.2 India Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.6.3 India Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.7 Japan
11.4.7.1 Japan Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.7.2 Japan Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.7.3 Japan Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.8 South Korea
11.4.8.1 South Korea Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.8.2 South Korea Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.8.3 South Korea Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.9 Vietnam
11.4.9.1 Vietnam Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.9.2 Vietnam Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.9.3 Vietnam Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.10 Singapore
11.4.10.1 Singapore Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.10.2 Singapore Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.10.3 Singapore Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.11 Australia
11.4.11.1 Australia Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.11.2 Australia Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.11.3 Australia Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Drug
11.4.12.2 Rest of Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Doses
11.4.12.3 Rest of Asia-Pacific Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Cold, Cough, and Sore Throat Remedies Market by country
11.5.1.2 Middle East Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.3 Middle East Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.4 Middle East Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.1.5 UAE
11.5.1.5.1 UAE Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.5.2 UAE Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.5.3 UAE Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.1.6 Egypt
11.5.1.6.1 Egypt Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.6.2 Egypt Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.6.3 Egypt Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.7.2 Saudi Arabia Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.7.3 Saudi Arabia Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.1.8 Qatar
11.5.1.8.1 Qatar Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.8.2 Qatar Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.8.3 Qatar Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.1.9.2 Rest of Middle East Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.1.9.3 Rest of Middle East Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by country
11.5.2.2 Africa Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.2.3 Africa Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.2.4 Africa Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.2.5.2 Nigeria Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.2.5.3 Nigeria Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.2.6 South Africa
11.5.2.6.1 South Africa Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.2.6.2 South Africa Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.2.6.3 South Africa Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Cold, Cough, and Sore Throat Remedies Market by Drug
11.5.2.7.2 Rest of Africa Cold, Cough, and Sore Throat Remedies Market by Doses
11.5.2.7.3 Rest of Africa Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.6 Latin America
11.6.1 Latin America Cold, Cough, and Sore Throat Remedies Market by country
11.6.2 Latin America Cold, Cough, and Sore Throat Remedies Market by Drug
11.6.3 Latin America Cold, Cough, and Sore Throat Remedies Market by Doses
11.6.4 Latin America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.6.5 Brazil
11.6.5.1 Brazil America Cold, Cough, and Sore Throat Remedies Market by Drug
11.6.5.2 Brazil America Cold, Cough, and Sore Throat Remedies Market by Doses
11.6.5.3 Brazil America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.6.6 Argentina
11.6.6.1 Argentina America Cold, Cough, and Sore Throat Remedies Market by Drug
11.6.6.2 Argentina America Cold, Cough, and Sore Throat Remedies Market by Doses
11.6.6.3 Argentina America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.6.7 Colombia
11.6.7.1 Colombia America Cold, Cough, and Sore Throat Remedies Market by Drug
11.6.7.2 Colombia America Cold, Cough, and Sore Throat Remedies Market by Doses
11.6.7.3 Colombia America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Cold, Cough, and Sore Throat Remedies Market by Drug
11.6.8.2 Rest of Latin America Cold, Cough, and Sore Throat Remedies Market by Doses
11.6.8.3 Rest of Latin America Cold, Cough, and Sore Throat Remedies Market by Distribution Channel
12 Company profile
12.1 Reckitt Benckiser.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Drug/Services/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Group PLC.
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Drug/Services/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Johnson & Johnson Services, Inc.,
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Drug/Services/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 GlaxoSmithKline plc.
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Drug/Services/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Novartis AG.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Drug/Services/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Bayer AG.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Drug/Services/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 AstraZeneca ple.
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Drug/Services/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Sun Pharmaceutical Industries Ltd.,
12.8.2 Financials
12.8.3 Drug/Services/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Pfizer Inc.,
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Drug/Services/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Prestige Brands Holdings, Inc.,
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Drug/Services/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Nicotine Replacement Therapy Market size was valued at USD 3.13 Billion in 2023 and is expected to reach USD 4.49 Billion By 2031 and grow at a CAGR of 4.61% over the forecast period of 2024-2031.
The Artificial Intelligence in Genomics Market Size was valued at USD 726.9 million in 2023 and is expected to reach USD 15007.1 million by 2031 and grow at a CAGR of 46.0% over the forecast period 2024-2031.
The Cold Pain Therapy Market size was estimated USD 1.7 billion in 2022 and is expected to reach USD 2.55 billion by 2030 at a CAGR of 5.2% during the forecast period of 2023-2030.
The DNA Synthesis Market size was estimated USD 3.46 billion in 2023 and is expected to reach USD 14.54 billion by 2031 at a CAGR of 19.62% during the forecast period of 2024-2031.
The Non-Invasive Fat Reduction Market Size was valued at USD 1.57 billion in 2022 and is expected to reach USD 5.33 billion by 2030, and grow at a CAGR of 16.5% over the forecast period 2023-2030.
The Neuroendoscopy Market size is projected to grow from $151.07 million in 2023 to $237.05 million by 2031, at a CAGR of 5.8% during the forecast period.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
